£1 million gift towards world-leading new centre for advancing eye health to enhance education
The Schroder Foundation and Family have donated £1 million to Moorfields Eye Charity towards the new centre for advancing eye health. The building is under construction and opening in 2027. Oriel is a joint initiative between Moorfields Eye Hospital NHS...
Biomarkers reveal how patients with glaucoma may respond to treatment
Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.
Children with ‘lazy eye’ are at increased risk of serious disease in adulthood
Adults who had amblyopia (‘lazy eye’) in childhood are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood, as well as an increased risk of heart attack, finds a new study led by UCL researchers.
Blindness from some inherited eye diseases may be caused by gut bacteria
Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher.
Transforming eyecare with AI at 100% Optical
“We are drowning in people we need to see in hospital eye services, and some people are going blind as a result. We are looking at nearly 10m hospital appointments for ophthalmology a year, with an approximately 33% increase over...
£5 million award for world-leading research facilities within new eye health centre
The Sir Jules Thorn Charitable Trust has awarded £5 million to UCL in partnership with Moorfields Eye Charity and Moorfields Eye Hospital to support Oriel – a centre for advancing eye health, opening in 2027.
Effective treatment for rare sight-threatening infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.
World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness
Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.
Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis
A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.